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Abstract- Multiple Sclerosis (MS) causes loss of the myelin sheath, which leads to loss of neurons. 
Regeneration of myelin sheath stimulates axon regeneration and neurons’ survival. In this study, olfactory 
ensheathing cell (OEC) transplantation is investigated to restore myelin sheath in an experimental model of 
MS in male mice.OECs were isolated from the olfactory mucosa of seven-day-old infant rats and cultured. 
Then, cells were evaluated and approved by flow cytometry by p75 and GFAP markers. A total of 32 mice 
(C57BL /6) were studied in four groups; 1) without any treatment (control), 2) Sham (receiving PBS), 3) MS 
model and 4) MS and OEC transplantation. MS was induced by adding Cuprizon in the diet of animals for six 
weeks. After the expiration of 20 days, histologic analysis was performed with approval of the presence of 
cells in the graft area and the removal of myelin and myelin regeneration with two types of luxal fast blue 
(LFB) staining and immunohistochemistry. The purity of the cells ensheathing the olfactory was 90%.  There 
was a significant difference in Myelin percentage of PBS and OEC recipient groups (P≤0.05). MBP and PLP 
of the myelin sheath in the group receiving OECs were more than MS group.According to the findings, in MS 
model MBP and PLP of the myelin sheath is reduced. In the group receiving OECs, it was returned to a 
normal level significantly compared to the sham group received only PBS significant differences were 
observed. The OECs transplantation can improve myelin restoration.  
© 2015 Tehran University of Medical Sciences. All rights reserved.  
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Introduction 
 
Multiple sclerosis (MS) is an autoimmune disease 
that effects on the central nervous system. This disease 
is characterized by three characteristics including 
inflammation, demyelination and scarring (1), and leads 
to sensory disorders, weakness, muscle cramps, visual 
disturbances, cognitive impairment, fatigue, tremor of 
limbs, disorders in passing urine and stool, sexual 
dysfunction, balance, amnesia, loss of hearing, 
numbness, blurred vision, double vision, speech disorder 
in some patients (2).  
Demyelination models in experimental animals are the 
best way to explore to find solutions for myelin 
restoration. Among the demyelination toxic models, EB 
ethidium bromide and cuprizon models can change the 
mitochondrial DNA, leading to abnormal breathing. This 
disorder can cause demyelination and necrosis (3,4).  
Demyelination means the destruction of myelin 
proteins placed around the axons of neurons in sheathing 
form. In the central nervous system, demyelination 
occurs by the direct attack to oligodendrocytes. On the 
other hand, the remyelination is a process in which the 
demyelinated axon is repaired. However, in 
remyelination, thinner and shorter myelin sheaths are 
produced; it can compensate mainly functional 
disorders. This process is the natural response of the 
body to the remyelination, but is disrupted in patient 
with MS. Therefore, axons remain in the demyelinated 
form in MS patients and they are susceptible to damage 
which can lead to neurological impairment. Although 
the reasons for the failure of remyelination in patients 
with MS are still uncertain, progresses in relation to 
understanding remyelination process was achieved (1).  
During the past few years, researchers have explored 
the possibility of cell transplantation with capacity of 
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migration, differentiation and ability regenerate myelin 
sheaths safely in target areas without any tend to become 
a tumoral form (4).  
Recently, the researchers have focused on olfactory 
ensheathing cells (OECs) transplantation, obtained from 
the olfactory mucosa, to treat the MS disease. OECs 
were injected into rats with damaged in the spinal cord 
as a treatment solution. These cells caused remyelination 
and reduction of scar components. Thus, with the 
reconstruction of the spine, the improvement of 
sensation and movement are increased. In these cases, 
OECs created an environment for axon growth (2). 
OECs are easily accessible and potentially used from 
adult cells of autologous population with good 
characteristics for remyelination (5).  
OECs are the type of glial cells, that show properties 
of astrocytes and Schwann cells. In this study, OEC cell 
transplantation was performed for the reconstruction of 
lost myelin areas after creating the demyelination. The 
evidence is based on histological analysis of 
transplanted cells remains in the lesion area and causes 
myelin repair (6).  
 
Materials and Methods 
 
Cell culture OEC  
Nash et al., method (7) with modifications was used 
for cell extraction and cell culture (8). For cell culture 
and isolation of OEC, seven-day-old rat infants were 
used. All animals were anesthetized by ketamine (75 mg 
/kg) and xylazine (10 mg /kg) intraperitoneally, and then 
heads were separated. The olfactory mucosa was 
separated from two sides of Vomer bone and after 
washing twice with 10 cc PBS containing antibiotics; 
lamina propria was separated with insulin needle and 
divided into smaller parts. Then several pipettes were 
poured into 15 falcon and 1cc trypsin  (1%) was added. 
It was incubated for 5 hours at 37° C and 5% CO2. Then 
it was centrifuged at 1200 RPM for 10 minutes to 
separate the cells from the tissues. The collected cells 
were placed in the bottom of the Falcon. The cell 
suspension was poured into the non-coat flask and it 
incubated for 18 hours at 37°C and % 5 CO2. During 
these times, the majority of fibroblasts were attached to 
the floor of the flasks. The supernatant was transferred 
to another uncovered flask, and incubated for 36 again. 
During this time, astrocytes were attached to the floor 
but the OECs were located in supernatant fluid. Then the 
supernatant fluid was transferred to the flask coated with 
poly-L-lysine and OEC cells attached to the floor of the 
plate for 48 hours (Figure 1:a). Flowcytometry was 
performed for confirmation OECs by using P75 and 
GFAP markers. According to the results, the purity of 
the cells was approximately 90% (8) (Figure 1:c). 
 
 
Figure 1. a: Adherent cells 18 h after cell suspension culture. b: Cell culture supernatants after 48 h of culture  
Flasks coated with poly-L-lysine transport c: Cells cultured in DMEM / F12 medium 
 
 
Tracing by DIL  
When the cells completely covered the floor of dish, 
they were separated by trypsin 0.25%. Then centrifuge 
was done and 5μg/ml DIL solution was added to the 
pellets (9) and incubated for 5 min at 37°c temperature. 
Then the cells were prepared for transplantation. 
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Induction of MS model  
A total of 32 mice (C57BL /6) were studied in 4 
groups; 1) without any treatment (control), 2) Sham 
(receiving PBS), 3) MS model and 4) treatment group: 
MS and OECs transplantation. MS model was induced 
by toxic substance Cuprizone, mixed (0.2%) with 
ordinary animal diet for six weeks (9). Feature of this 
approach is that it causes demyelination of the corpus 
callosum and upper cerebellum peduncle (Figure3b) 
(10)  
 
Cell transplantation  
About 0.5 μL of OEC suspension contains one 
hundred thousand cells injected by Stereotaxic method 
and intraparenchymal technique into corpus callosum of 
mice. In this method, after six weeks, animals were 
anesthetized by IP injection of ketamine (ketamine 
hydrochloride) and xylazine, then placed on the 
stereotaxic apparatus, and fixed. After opening the skull 
and identification of Lambda and bregma, (11) the 
injection site was determined. Then OECs were injected 
by a Hamilton syringe into the corpus callosum. PBS 
was was injected to six other mice (12). 
 
Histological evaluation of the brain  
After 20 days of cells injection, brain fixation was 
performed. At first, animals were anesthetized with 
ketamine and xylazine and then perfused with 
paraformaldehyde 4% (Sigma, USA) soluble in PBS 0.1 
M and glutaraldehyde. Then, the mice brains were 
removed and placed in the same fixative for one night. 
After that, it was placed in 10% sucrose soluble for other 
one night and it was ready for tissue preparation. Serial 
transverse sections were performed by microtome and 
with 7 um thickness of each slice was micrometers (13). 
Immunocytochemistry 
Incubated cells were fixed in 4% paraformaldehyde 
(Sigma, USA). Fixed cells were washed with PBS and 
permeabilized with 0.1% Triton X-100 (Sigma, United 
States of America) in PBS, in blocking buffer (PBS, 1 
mg/ml BSA (Sigma, USA) and goat serum 10% (Gibco, 
USA) and followed was placed by incubation with 
primary antibodies one night at 4°C. Then cells were 
washed with PBS and incubated with the species-
specific secondary antibody . 
Culture with three changes of PBS, and nuclei were 
stained with diamidino-2-4-6 phenylindole and observed 
by fluorescent microscopy and were washed. Expression 
of nerve growth factor receptor p75 low-affinity OEC 
culture were detected by immunostaining of cells with 
anti-p75 primary monoclonal antibodies in mice NGFR 
(Sigma, USA) and IgG antimouse FITC conjugated 
secondary antibody (Abcam, USA). Protein expression 
of terror with microtubule 2 (MAP2) ΒIII-tubulin in 
mouse ES cells were differentiated primary cells 
visualized by immunostaining Mouse monoclonal anti-
MAP2 and tubulin βII (Sigma, USA) and phycoerythrin 
conjugated secondary anti-mouse IgG antibody (Abcam, 
USA).  
 
Results 
 
The histological results in the studied groups 
The remyelination was measured with the 
olisabioreport software and reported in quantitative 
form. To confirm luxal fast blue (LFB) staining, 
immunohistochemistry was performed and reported in 
qualitative form (Figures 1-3).  
 
 
Figure 2. Immunocytochemistry Olfactory ensheathing cells expressing p75(A) and GFAP(B) 
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Figure 3. A: OEC effects on remyelination in MS model of mice 
*significant difference between control and other groups (Model and treatment) (P≤0.05), #significant difference between model and treatment 
group (P≤0.05). b: effects on remyelination in MS model of mice. a: control, b: model, c: sham, d: treatment (luxol fast blue) 
 
In a model group, demyelination was present in the 
affected area and the amount of remyelination was few 
or not seen (10). OECs were present at high levels in the 
damaged nerve cells. Remyelination was observed at the 
injection site and its surroundings (14). Myelinated 
fibers were observed In LFB staining of neurons (15). A 
large myelin repaired area was observed in the treatment 
group by specifying color filter of DIL (Figure 6). There 
was a significant difference in Myelin percentage of 
PBS and OEC recipient groups (P≤0.05).  
 
 
Figure 4. Immunohistochemistry OEC cells with antibodies MBP. OEC effects on remyelination in MS model of mice.  
a:control, b:model, c:sham, d:treatment MBP 
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Figure 5. Immunohistochemistry OEC cells with antibodies PLP. OEC effects on remyelination in MS model of mice.  
a:control, b:model, c:sham, d:treatment PLP 
 
 
 
Figure 6. Tracing with DII 
 
 
Discussion 
 
T Sensitized cells can pass through the blood-brain 
barrier. Their task is to control the presence of CNS 
antigens and then leave the area. In MS, T sensitized 
cells remain in CNS and can help to infiltration of other 
factors that may lead to loss of the immune system. 
Attack to the immune system can cause inflammation. 
Inflammation can eliminate the myelin sheet (which 
normally covers the axon to speed the impulses along 
the axon) and the cells that produce myelin in the CNS. 
Sclerosed plaques appear in the path of demyelinated 
axons and create more interruption in the transmission 
of impulses. MRI is considered the first diagnostic tool 
for detection of small plaques and evaluating the process 
of treatment . 
There are two main goals in the treatment researches of 
MS disease. 
- Myelin retrieval and regeneration 
-The replacement of lost cells, such as 
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oligodanderosite 
Different cells were used for replacement of lost 
cells, but one of the most important cells of myelin 
regeneration is OECs. The results of the research 
showed that the transplantation of OECs in MS models 
can restore the myelin sheath. In this study, the average 
myelin restoration in the treatment group was more than 
MS group. 
OECs were isolated from the olfactory mucosa. 
During OECs isolation in the multi-stage process, 
different cell lines were obtained. Nash et al., showed that 
70% of the cells in the first phase of culturing, attached to 
the floor of the flask are fibroblasts (7). The supernatant 
was transferred to another uncovered flask and were 
incubated for 36 hrs. During this time, 67% of cells 
attached to the floor of the flask are astrocytes. But the 
OECs are located in the supernatant. Then supernatants 
were transferred to the covered flask with poly-L-lysine 
and within 48 hours, the OECs attached to the floor of the 
plate. 
OECs were confirmed by the P75 and GFAP 
markers in flowcytometry. In the present study, the 
purity of OECs was approximately 90% (7,8). 
Cuprizone powders (mixed 0.2% with diet for six 
weeks) was used for MS induction (9). Then, 
demyelination of corpus callosum was confirmed by 
LFB and immunohistochemical (MBP (Figure 4) and 
PLP (Figure 5) markers) which was similar to previous 
studies (10). In this study, OECs were used for 
restoration of myelin and according to the results a large 
area of remyelination in the damaged area was observed 
in the treatment group. 
Several studies have been performed to evaluate 
OECs and its effects on spinal cord injuries. 
Improvement has been observed just in some studies 
(16). The results of this study showed that the 
transplanted cells OEC can restore the myelin sheath in 
mice model of MS. In this study average myelin 
restoration in the treatment group were more than the 
sham group and the model that was similar to previous 
studies (10). However, some studies have reported that 
the OEC is unable to restore the myelin sheath (16). The 
reasons for these conflicting reports are not clear. But 
the some factors such as the type of injury, cells culture 
method of OECs, purity degree, and the time of 
transplantation can effect on the result of studies (17). 
Despite, the majority of studies suggest axonal 
regeneration was improved. Feron et al., (2005) 
transplanted OECs into the damaged spinal cord. 
Regeneration of Myelin in downside routes and 
significant improvement of locomotor function in aimals 
received transplantation were observed (18).  Kato et al., 
(2000) reported although transplanted Schwann cells can 
improve the myelin sheets in the injured area alone, 
transplantation Schwann cells with astrocytes had better 
results with much wider remyelination areas. Since the 
OECs shows properties of both cells astrocyte and 
Schwann like cell and they are able to restore axonal 
conduction without cotransplantation with astrocytes 
(19). Barnett et al., showed that induction by OECs can 
myelinate axons in vitro four weeks (20). Then, further 
studies on the mechanism of OECs myelin regeneration 
indicated that this ability of OECs associated with age 
and the response of myelin occurs in fetal compared 
with adult OEC (21). Several studies have shown that 
OEC myelin causes spinal cord injury SCI (22). This 
myelin has a normal structure (23). 
The present study demonstrated that the OECs 
transplantation can improve myelin restoration. This 
finding is consistent with the findings of other 
researchers. In MS model MBP and PLP of the myelin 
sheath are reduced. In the group receiving OECs, it was 
returned to normal level significantly compared to the 
sham group received only PBS  
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